-
Lexicon's Sotagliflozin Shows Benefits in Heart Failure, Blood Glucose Control
Monday, November 15, 2021 - 4:02pm | 163Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) has announced a new analysis evaluating the benefit of sotagliflozin in heart failure and blood glucose control across the full range of kidney function. In the new analysis of pooled data from the SOLOIST and SCORED trials, sotagliflozin...
-
McKesson, Cardinal Health, AmerisourceBergen Face $95B Opioid Trial In Washington: Reuters
Monday, November 15, 2021 - 3:30pm | 414A Washington state trial against McKesson Corporation (NYSE: MCK), Cardinal Health Inc (NYSE: CAH), and AmerisourceBergen Corp (NYSE: ABC) for the U.S. opioid epidemic is slated to kick off today, Reuters reported. Washington Attorney General Bob Ferguson...
-
Labcorp In Talks To Merge Some Covance Assets With Syneos: Bloomberg
Friday, November 12, 2021 - 10:27am | 207Laboratory Corp of America Holdings (NYSE: LH) is in talks to combine some of its assets with Syneos Health Inc (NASDAQ: SYNH), reports Bloomberg citing people with knowledge of the matter. The companies are discussing a deal in which part of LabCorp's Covance...
-
Cue Health Reports Q3 Profit On Higher Sales, Annual Guidance Above Consensus
Thursday, November 11, 2021 - 8:38am | 210Cue Health Inc (NASDAQ: HLTH) reported Q3 sales of $223.7 million, compared to +63% sequentially. Public Sector revenue was $129.5 million, compared to $105.0 in Q2 FY21, driven by additional deliveries to DOD / HHS under the existing agreement. Private Sector revenue was $94.2 million,...
-
Ligand To Spin-Off OmniAb Platform Into Its Own Independent Company
Wednesday, November 10, 2021 - 1:23pm | 277Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced plans to split into two separate publicly traded companies. One company will feature the OmniAb business, and the other housing Ligand’s existing royalties and technologies, including its Pelican protein expression...
-
81 Biggest Movers From Yesterday
Friday, November 5, 2021 - 5:01am | 2588Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) jumped 79.8% to settle at $4.26 after the company entered into a securities purchase agreement with certain investors for a...
-
5 Stocks Insiders Are Selling
Wednesday, November 3, 2021 - 7:54am | 690When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading...
-
51 Stocks Moving In Tuesday's Mid-Day Session
Tuesday, November 2, 2021 - 12:06pm | 1834Gainers Avis Budget Group, Inc. (NASDAQ: CAR) surged 83.9% to $315.37 after the company reported better-than-expected Q3 adjusted EPS and sales results and added $1 billion to its buyback. The OLB Group, Inc. (NASDAQ: OLB) shares climbed 76.9% to $8.12 after the company announced support for...
-
10 Biggest Price Target Changes For Tuesday
Tuesday, November 2, 2021 - 8:17am | 376JP Morgan lowered The Clorox Company (NYSE: CLX) price target from $171 to $147. Clorox shares rose 2.1% to $166.80 in pre-market trading. Jefferies boosted the price target for Alcoa Corporation (NYSE: AA) from $52 to $60. Alcoa shares rose 0.7% to $47.06 in pre-market trading. Keybanc cut...
-
McKesson Posts Better Than Expected Q2 Earnings; Raises FY22 EPS Outlook Again
Tuesday, November 2, 2021 - 6:34am | 269McKesson Corp (NYSE: MCK) reported second-quarter FY22 adjusted EPS of $6.15, +28% Y/Y, and easily beating the analyst consensus of $4.66. Revenues increased 9% Y/Y to $66.57 billion, surpassing the consensus of $63.12 billion, driven by growth in the U.S. Pharmaceutical segment,...
-
A Peek Into The Markets: US Stock Futures Edge Lower; Fed Meeting In Focus
Tuesday, November 2, 2021 - 6:00am | 702Pre-open movers U.S. stock futures traded slightly lower in early pre-market trade after settling at record highs in the previous session. The Federal Open Market Committee will start its two-day policy meeting today. Investors are awaiting earnings results from Pfizer Inc. (NYSE: PFE), T-Mobile...
-
5 Stocks To Watch For November 2, 2021
Tuesday, November 2, 2021 - 4:08am | 322Some of the stocks that may grab investor focus today are: Wall Street expects Pfizer Inc. (NYSE: PFE) to report quarterly earnings at $1.08 per share on revenue of $22.41 billion before the opening bell. Pfizer shares rose 0.8% to $44.00 in after-hours trading. McKesson Corporation (NYSE: MCK)...
-
A Peek Into The Markets: US Stock Futures Higher Ahead Of Manufacturing Data
Monday, November 1, 2021 - 6:05am | 749Pre-open movers U.S. stock futures traded higher in early pre-market trade after closing at record highs in the previous session. Investors are awaiting earnings results from PG&E Corporation (NYSE: PCG), McKesson Corporation (NYSE: MCK), Clorox Co (NYSE: CLX), and ON Semiconductor Corp...
-
5 Stocks To Watch For November 1, 2021
Monday, November 1, 2021 - 2:51am | 314Some of the stocks that may grab investor focus today are: Wall Street expects PG&E Corporation (NYSE: PCG) to report quarterly earnings at $0.26 per share on revenue of $5.37 billion before the opening bell. PG&E shares rose 0.6% to $11.67 in after-hours trading. Xpeng Inc - ADR (NYSE...
-
Ligand Outlicenses BEPro Tech To Develop Oral COVID-19 Antivirals
Thursday, October 21, 2021 - 1:13pm | 225Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) has signed a collaboration agreement with Double-Crane Pharmaceutical Co Ltd (CRDC). The agreement grants CRDC exclusive Asia territorial rights to develop an oral COVID-19 antiviral using Ligand's BEPro technology....